Bob van de Loo

Bob van de Loo is a Researcher at the Department of Pharmacy, Erasmus University Medical Center in Rotterdam, Netherlands. His work focuses on clinical pharmacology and pharmacoepidemiology, particularly in geriatric populations and infectious disease outcomes.

Research interests include:

• Pharmacotherapy effects in COVID-19 and SARS coronavirus
• Frailty and mortality risk assessment in elderly patients
• Clinical decision-making in triage scenarios
• Cohort studies on medication safety and outcomes

His recent publications (2020-2025) demonstrate a consistent focus on COVID-19 outcomes, frailty assessment, and pharmacological interventions. Research methodologies emphasize large-scale cohort studies and clinical trial protocols in collaboration with multidisciplinary teams like the COMET Research Group.

No scientific awards, grants, or student advising relationships are documented in available sources.